Rubedo Life Sciences
Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $40.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Rubedo Life Sciences is a pioneering company in the field of longevity, focusing on developing therapeutics aimed at combating age-related diseases and extending healthy lifespan. The company operates primarily in the life sciences market and serves clients ranging from individual patients to large healthcare institutions. Rubedo Life Sciences employs a business model that combines cutting-edge research with clinical applications, generating revenue through the development and commercialization of novel therapies. The company leverages its expertise in oncodermatology and skin health to advance cancer care and improve the quality of life for patients. Located in Silicon Valley, California, Rubedo Life Sciences is led by a team of renowned scientists and entrepreneurs with a deep passion for longevity science.
Keywords: longevity, therapeutics, age-related diseases, healthy lifespan, life sciences, oncodermatology, skin health, cancer care, Silicon Valley, clinical trials.